Please login to the form below

Not currently logged in
Email:
Password:

Flucelvax

This page shows the latest Flucelvax news and features for those working in and with pharma, biotech and healthcare.

GSK gets OK for second quadrivalent flu vaccine in US

GSK gets OK for second quadrivalent flu vaccine in US

Instead, the Swiss firm has focused its R&D investment on switching from egg-based to cell culture-based production, securing approval for its FluCelVax product in November 2012.

Latest news

  • GSK's four-strain flu vaccine debuts in the US GSK's four-strain flu vaccine debuts in the US

    Novartis has concentrated on developing cell-manufactured flu vaccines, having recently won approval in the US for its Flucelvax trivalent candidate, and is arguably lagging in the quadrivalent stakes.

  • Novartis gets US approval for Flucelvax flu jab made in cells Novartis gets US approval for Flucelvax flu jab made in cells

    It added that, unlike conventional flu vaccines, Flucelvax does not contain preservative such as thimerosal. ... Flucelvax will be produced in Holly Springs once the facility is ready for full-scale commercial production," said Novartis in a statement.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics